Alkeon Capital Management LLC lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 50.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,003,278 shares of the semiconductor company’s stock after buying an additional 335,000 shares during the quarter. Synopsys makes up 0.7% of Alkeon Capital Management LLC’s investment portfolio, making the stock its 18th largest position. Alkeon Capital Management LLC owned about 0.52% of Synopsys worth $471,260,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Synopsys during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the fourth quarter worth about $28,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Synopsys during the fourth quarter worth about $32,000. Oakworth Capital Inc. grew its holdings in shares of Synopsys by 3,700.0% during the fourth quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock worth $36,000 after buying an additional 74 shares in the last quarter. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in shares of Synopsys during the third quarter worth about $38,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.
Synopsys Trading Up 0.1%
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s revenue was up 41.9% compared to the same quarter last year. During the same period in the previous year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.
Wall Street Analyst Weigh In
SNPS has been the subject of a number of recent research reports. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. BNP Paribas Exane raised their target price on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Rosenblatt Securities raised their target price on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research report on Tuesday, May 26th. Wells Fargo & Company raised their target price on shares of Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 target price on shares of Synopsys in a research report on Wednesday, May 27th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $563.81.
Get Our Latest Research Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
